|
1
|
Chen J, Zhu S, Xie XZ, et al: Analysis of
clinicopathological factors associated with bone metastasis in
breast cancer. J Huazhong Univ Sci Technolog Med Sci. 33:122–125.
2013.
|
|
2
|
Chu QD, Holm NT, Madumere P, et al:
Chemokine receptor CXCR4 overexpression predicts recurrence for
hormone receptor-positive, node-negative breast cancer patients.
Surgery. 149:193–199. 2011.
|
|
3
|
Hiller D and Chu QD: CXCR4 and axillary
lymph nodes: review of a potential biomarker for breast cancer
metastasis. Int J Breast Cancer. 2011:4209812011.
|
|
4
|
Hiller DJ, Li BD and Chu QD: CXCR4 as a
predictive marker for locally advanced breast cancer
post-neoadjuvant therapy. J Surg Res. 166:14–18. 2011.
|
|
5
|
Andre F, Xia W, Conforti R, et al: CXCR4
expression in early breast cancer and risk of distant recurrence.
Oncologist. 14:1182–1188. 2009.
|
|
6
|
Rhodes LV, Short SP, Neel NF, et al:
Cytokine receptor CXCR4 mediates estrogen-independent
tumorigenesis, metastasis, and resistance to endocrine therapy in
human breast cancer. Cancer Res. 71:603–613. 2011.
|
|
7
|
Weiss ID and Jacobson O: Molecular imaging
of chemokine receptor CXCR4. Theranostics. 3:76–84. 2013.
|
|
8
|
Albert S, Riveiro ME, Halimi C, et al:
Focus on the role of the CXCL12/CXCR4 chemokine axis in head and
neck squamous cell carcinoma. Head Neck. 35:1819–1828. 2013.
|
|
9
|
Luker KE and Luker GD: Functions of CXCL12
and CXCR4 in breast cancer. Cancer Lett. 238:30–41. 2006.
|
|
10
|
Peled A and Tavor S: Role of CXCR4 in the
pathogenesis of acute myeloid leukemia. Theranostics. 3:34–39.
2013.
|
|
11
|
Katsumoto K and Kume S: The role of
CXCL12-CXCR4 signaling pathway in pancreatic development.
Theranostics. 3:11–17. 2013.
|
|
12
|
Mukherjee D and Zhao J: The Role of
chemokine receptor CXCR4 in breast cancer metastasis. Am J Cancer
Res. 3:46–57. 2013.
|
|
13
|
Parker CC, Kim RH, Li BD and Chu QD: The
chemokine receptor CXCR4 as a novel independent prognostic marker
for node-positive breast cancer patients. J Surg Oncol.
106:393–398. 2012.
|
|
14
|
Gil M, Seshadri M, Komorowski MP, et al:
Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy
disrupts tumor vasculature and inhibits breast cancer metastases.
Proc Natl Acad Sci USA. 110:E1291–E1300. 2013.
|
|
15
|
Ling X, Spaeth E, Chen Y, et al: The CXCR4
antagonist AMD3465 regulates oncogenic signaling and invasiveness
in vitro and prevents breast cancer growth and metastasis in vivo.
PLoS One. 8:e584262013.
|
|
16
|
Hernandez L, Magalhaes MA, Coniglio SJ, et
al: Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
Breast Cancer Res. 13:R1282011.
|
|
17
|
Wendel C, Hemping-Bovenkerk A, Krasnyanska
J, et al: CXCR4/CXCL12 participate in extravasation of
metastasizing breast cancer cells within the liver in a rat model.
PLoS One. 7:e300462012.
|
|
18
|
Sacanna E, Ibrahim T, Gaudio M, et al: The
role of CXCR4 in the prediction of bone metastases from breast
cancer: a pilot study. Oncology. 80:225–231. 2011.
|
|
19
|
Wang J, Loberg R and Taichman RS: The
pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
Cancer Metastasis Rev. 25:573–587. 2006.
|
|
20
|
Ping YF, Yao XH, Jiang JY, et al: The
chemokine CXCL12 and its receptor CXCR4 promote glioma stem
cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT
signalling. J Pathol. 224:344–354. 2011.
|
|
21
|
Zheng H, Fu G, Dai T and Huang H:
Migration of endothelial progenitor cells mediated by stromal
cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal
transduction pathway. J Cardiovasc Pharmacol. 50:274–280. 2007.
|
